Cargando…
Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response
Leishmaniasis is a parasitic disease that is prevalent in 90 countries, and yet no licensed human vaccine exists against it. Toward control of leishmaniasis, we have developed Leishmania major centrin gene deletion mutant strains (LmCen(−/−)) as a live attenuated vaccine, which induces a strong IFN-...
Autores principales: | Oljuskin, Timur, Azodi, Nazli, Volpedo, Greta, Bhattacharya, Parna, Markle, Hannah L., Hamano, Shinjiro, Matlashewski, Greg, Satoskar, Abhay R., Gannavaram, Sreenivas, Nakhasi, Hira L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517402/ https://www.ncbi.nlm.nih.gov/pubmed/37744403 http://dx.doi.org/10.1016/j.isci.2023.107593 |
Ejemplares similares
-
Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes
por: Volpedo, Greta, et al.
Publicado: (2023) -
The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
por: Volpedo, Greta, et al.
Publicado: (2022) -
Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
por: Ismail, Nevien, et al.
Publicado: (2022) -
Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2022) -
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021)